A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)

NCT00511667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MK0941
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC